MetaTrader
  • Markets
  • Charts & Ideas
  • Algo
  • Noticias
  • Store
  • Corredores
  • Descargar
  • Calendario económico
  • Señales Comerciales
  • WebTerminal
  • English English
  • Русский Русский
  • 中文 中文
  • Español Español
  • Português Português
  • 日本語 日本語
  • Deutsch Deutsch
  • 한국어 한국어
  • Français Français
  • Türkçe Türkçe
Foghorn Therapeutics Inc. Common Stock

FHTX

#2701
Foghorn Therapeutics Inc. Common Stock
5.6800
+0.89%
Sector:
Básica:
Profit Currency:
Rango diario
5.6800
5.6800
Rango anual
3.2700
6.9500
Cambio diario
+0.89%
Monthly Change
-3.97%
6 month change
+39.22%
Cambio anual
+39.22%
Cierres anteriores
5.6300
Open
5.6800
Bid
Ask
Low
5.6800
High
5.6800
Volumen
33
  1. Markets
  2. Acciones
  3. Atención Sanitaria
  4. FHTX
Open full chart

Financials

Overview Statement Statistics Dividends
Quarterly Annual
Value Q3, 24Q4, 24Q1, 25Q2, 25Q3, 25 TTM

Noticias

Investing Investing
FHTX
2026.02.23
Foghorn Therapeutics nomina Ryan Maynard come direttore finanziario
Investing Investing
FHTX
2026.02.23
Foghorn Therapeutics names Ryan Maynard as chief financial officer
Investing Investing
FHTX
2026.02.17
Jefferies initiates Foghorn Therapeutics stock with buy rating
Investing Investing
ALDX AVTX ESTA GH FHTX
2026.02.05
I migliori titoli sanitari per quest’anno secondo BTIG
Investing Investing
ALDX AVTX ESTA GH FHTX
2026.02.05
Top Healthcare Stocks for This Year According to BTIG
Investing Investing
FHTX
2026.01.13
Azioni Foghorn Therapeutics riconfermate come Acquisto da BTIG, nominate top pick per il 1H26
Investing Investing
FHTX
2026.01.13
Foghorn Therapeutics stock reaffirmed as Buy by BTIG, named top pick for 1H26
Investing Investing
FHTX
2026.01.12
Stifel conferma il rating Buy sulle azioni di Foghorn Therapeutics con target di $12
Investing Investing
FHTX
2026.01.12
Stifel reiterates Buy rating on Foghorn Therapeutics stock at $12 target
Zacks Zacks
JNJ PFE MRK LLY ABBV
2025.12.18
3 Cancer Stocks to Buy Amid Rapid Advances in Cancer Treatment
Investing Investing
LLY FHTX
2025.12.18
BTIG avvia la copertura su Foghorn Therapeutics con rating Buy grazie alla pipeline oncologica
Investing Investing
LLY FHTX
2025.12.18
BTIG initiates Foghorn Therapeutics stock with Buy rating on cancer pipeline

Markets

  • Acciones
  • Divisas
  • Criptomonedas
  • Metales
  • Mercancías

Charts & Ideas

  • Ideas comerciales
  • Ideas ilustrativas
  • Gráfico

MQL5 Community

  • Market
  • Señales
  • Foro
  • Artículos
  • CodeBase

Noticias

  • Acciones
  • Divisas
  • Criptomonedas
  • Metales
  • Mercancías

Corredores

  • Todos los brókeres
  • Fórex
  • Acciones
  • Metales
MetaTrader 5
MQL5 Channels
Economic Calendar
Disclaimer and Risk Disclosure Terms of Use Información y contacto Legal
Copyright 2000-2026, MetaQuotes Ltd